News

An MUSC research team reports in Cells that the complement system, part of the body's natural immune defenses, is a key ...
After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and ...
The less time a tick has to feed, the less saliva it can pump in, and the fewer tricks it can use to tilt the odds. For ...
Our diets can affect our health, but despite extensive research, we still don’t have a great understanding ... | Cell And ...
Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...
Apellis Pharmaceuticals, Inc. ( NASDAQ: APLS) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 8:45 AM EDT ...
The relationship between the gut microbiome and the human body is complex. While the microbes in the human gastrointestinal tract have major impact .. | Genetics And Genomics ...
Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.